Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer

Internal Medicine Journal

Volumn 38, Issue 4, 2008, Pages 265-269

  Gibbs, P ^a,b   Handolias, D ^a   McLaughlin, S ^a   Chapman, M ^a   Johns, J ^a   Faragher, I ^a  

^a WESTERN HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Adjuvant; Chemotherapy; Colon cancer; Completion; Elderly; Toxicity

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED;

EID: 41549109959     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01520.x     Document Type: Article

References (12)

1. Australian Institute of Health and Welfare and Australian Association of Cancer Registries. Cancer in Australia 2001. Canberra, Australia : AIHW 2004 Cat. No. CAN 23, Cancer Series No. 28.
2. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990 322 : 352 8.
3. Haydon A. Adjuvant chemotherapy in colon cancer: what is the evidence? Intern Med J 2003 33 : 119 24.
4. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004 350 : 2343 51.
5. Wolmark N, Wieand S, Kuebler JP, Colangelo L, Smith RE. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: results of NSABP protocol C-07. Proc Am Soc Clin Oncol 2005 35 : A3500.
6. Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials. Intern Med J 2006 36 : 216 20.
7. Rodrigues J, Lim E, McLaughlin S, Faragher I, Skinner I, Chao M et al. The influence of language spoken on colorectal cancer diagnosis and management. ANZ J Surg 2006 76 : 671 2.
8. Semmens JB, Platell C, Threlfall TH, Holman CD. A population-based study of the incidence, mortality and outcomes in patients following surgery for colorectal cancer in Western Australia. Aust N Z J Surg 2000 70 : 11 18.
9. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002 20 : 3992 8.
10. Chau I, Norman AR, Cunningham D, Tait D, Ross PJ, Iveson T et al. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol 2005 16 : 549 57.
11. Twelves C, Wong A, Nowacki MP, Abt M, Burris H, Carrato A et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005 352 : 2696 704.
12. Lembersky BC, Wieand HS, Petrelli NH, O'Connell MJ, Colangelo LH, Smith RE et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol 2006 24 : 2059 64.